Intended for healthcare professionals

Letters Diagnosing prostate cancer in asymptomatic patients

Authors’ reply to Booth and colleagues

BMJ 2022; 378 doi: (Published 13 July 2022) Cite this as: BMJ 2022;378:o1719
  1. Stephen H Bradley, clinical research fellow and GP1,
  2. Garth Funston, National Institute for Health and Care Research (NIHR) academic clinical fellow2,
  3. Daniel Jones, NIHR academic clinical lecturer1,
  4. Jessica Watson, NIHR academic clinical lecturer3
  1. 1University of Leeds, Leeds, UK
  2. 2University of Manchester, Manchester, UK
  3. 3University of Bristol, Bristol, UK
  1. medsbra{at}

We thank Booth and colleagues for their comments.1 As we outlined in our editorial,2 we agree that the use of magnetic resonance imaging has been an important development which has reduced the need for biopsy along with its associated harms. While we did not offer an opinion as to whether a programme …

View Full Text

Log in

Log in through your institution


* For online subscription